Theranostics 2018; 8(18):5072-5087. doi:10.7150/thno.26546 This issue Cite

Review

The impact of cancer-associated fibroblasts on major hallmarks of pancreatic cancer

Qiqing Sun1,2,3,4#, Bo Zhang1,2,3,4#, Qiangsheng Hu1,2,3,4, Yi Qin1,2,3,4, Wenyan Xu1,2,3,4, Wensheng Liu1,2,3,4, Xianjun Yu1,2,3,4✉, Jin Xu1,2,3,4✉

1. Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
2. Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China.
3. Pancreatic Cancer Institute, Fudan University, Shanghai 200032, China.
4. Shanghai Pancreatic Cancer Institute, Shanghai 200032, China.
# These authors contributed equally to this article.

Citation:
Sun Q, Zhang B, Hu Q, Qin Y, Xu W, Liu W, Yu X, Xu J. The impact of cancer-associated fibroblasts on major hallmarks of pancreatic cancer. Theranostics 2018; 8(18):5072-5087. doi:10.7150/thno.26546. https://www.thno.org/v08p5072.htm
Other styles

File import instruction

Abstract

Graphic abstract

Pancreatic ductal adenocarcinoma (PDAC) constitutes one of the most challenging lethal tumors and has a very poor prognosis. In addition to cancer cells, the tumor microenvironment created by a repertoire of resident and recruited cells and the extracellular matrix also contribute to the acquisition of hallmarks of cancer. Among these factors, cancer-associated fibroblasts (CAFs) are critical components of the tumor microenvironment. CAFs originate from the activation of resident fibroblasts and pancreatic stellate cells, the differentiation of bone marrow-derived mesenchymal stem cells and epithelial-to-mesenchymal transition. CAFs acquire an activated phenotype via various cytokines and promote tumor proliferation and growth, accelerate invasion and metastasis, induce angiogenesis, promote inflammation and immune destruction, regulate tumor metabolism, and induce chemoresistance; these factors contribute to the acquisition of major hallmarks of PDAC. Therefore, an improved understanding of the impact of CAFs on the major hallmarks of PDAC will highlight the diagnostic and therapeutic values of these targeted cells.

Keywords: pancreatic cancer, tumor microenvironment, hallmarks of cancer, cancer-associated fibroblast


Citation styles

APA
Sun, Q., Zhang, B., Hu, Q., Qin, Y., Xu, W., Liu, W., Yu, X., Xu, J. (2018). The impact of cancer-associated fibroblasts on major hallmarks of pancreatic cancer. Theranostics, 8(18), 5072-5087. https://doi.org/10.7150/thno.26546.

ACS
Sun, Q.; Zhang, B.; Hu, Q.; Qin, Y.; Xu, W.; Liu, W.; Yu, X.; Xu, J. The impact of cancer-associated fibroblasts on major hallmarks of pancreatic cancer. Theranostics 2018, 8 (18), 5072-5087. DOI: 10.7150/thno.26546.

NLM
Sun Q, Zhang B, Hu Q, Qin Y, Xu W, Liu W, Yu X, Xu J. The impact of cancer-associated fibroblasts on major hallmarks of pancreatic cancer. Theranostics 2018; 8(18):5072-5087. doi:10.7150/thno.26546. https://www.thno.org/v08p5072.htm

CSE
Sun Q, Zhang B, Hu Q, Qin Y, Xu W, Liu W, Yu X, Xu J. 2018. The impact of cancer-associated fibroblasts on major hallmarks of pancreatic cancer. Theranostics. 8(18):5072-5087.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image